Agriculture: Genetically Modified Crops

House of Lords written question – answered on 12th November 2010.

Alert me about debates like this

Photo of Lord Powell of Bayswater Lord Powell of Bayswater Crossbench

To ask Her Majesty's Government what criteria they intend to apply to determine whether plant, fungal and algal products are regulated as food or as medicine after 30 April 2011, in the light of advances in nutrigenomic science illuminating how food bioactive components (nutrients and non-nutrients) can influence gene expression.

Photo of Earl Howe Earl Howe The Parliamentary Under-Secretary of State for Health

There is no mention of the term "nutrigenomic" in the medicines directive 2001/83. The decision as to whether a product falls within the definition of a medicinal product is made by the Medicines and Healthcare Products Regulatory Agency (MHRA) on a case-by-case basis using the definition of that term contained in Article 1 of the directive. The criteria that the MHRA takes into account are set out in their document Guidance Note 8: A Guide to What is a Medicinal Product. This can be found on the MHRA website at publication/co007.pdf.

The criteria include all presentational material and available scientific evidence or information on any pharmacological, metabolic or immunological function of the ingredients. The approach that the MHRA takes is in line with the relevant judgments of the European Court.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.